Amlodipine Besylate Tablet
Product Images NDC 0904-6370

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 0904-6370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

89ddd1bc 9088 4204 8554 D25848ae6b16 01

Chemical structure diagram of amlodipine besylate, showing its molecular framework with labeled atoms and bonds representing the compound's chemical composition.*

FDA Label Image

89ddd1bc 9088 4204 8554 D25848ae6b16 02

A line graph comparing event rates over time (months) between Amlodipine and Placebo groups. The x-axis represents time in months up to 24 months, and the y-axis shows the event rate ranging from 0 to 0.25. The graph includes statistical data: P-value of 0.003, Hazard Ratio of 0.691, and a 95% confidence interval from 0.54 to 0.88. The number of participants at risk is indicated below the x-axis at multiple time points.*

FDA Label Image

89ddd1bc 9088 4204 8554 D25848ae6b16 03

A forest plot chart depicting the hazard ratio with 95% confidence intervals comparing amlodipine to placebo across various patient subgroups for a clinical study. Subgroups include overall patients, age groups, gender, baseline sitting systolic blood pressure (SBP), baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. The horizontal axis shows hazard ratios from 0 to 2, with a vertical line at 1 indicating no difference between amlodipine and placebo.*

FDA Label Image

Image 01

Label for Amlodipine Besylate tablets, USP 2.5 mg by Major Pharmaceuticals. The label indicates unit dose packaging with 100 tablets per package, Rx only. It includes dosage strength, manufacturer and distributor information, storage instructions, and a note to dispense with patient information leaflet.*

FDA Label Image

Image 02

Packaging label for Amlodipine Besylate Tablets, USP 5 mg oral tablets by Major Pharmaceuticals. The unit dose package contains 100 tablets. The label includes instructions to dispense with patient information leaflet, storage temperature, and cautions. Manufactured by Cadila Healthcare Ltd., distributed by Major Pharmaceuticals and Zydus Pharmaceuticals USA Inc.*

FDA Label Image

Image 03

Amlodipine Besylate 10 mg oral tablets, unit dose packaging from Major Pharmaceuticals. The label displays the product name and strength prominently in red and brown text. It includes dispensing instructions for pharmacists, a quantity of 100 tablets, storage conditions, and distribution information including Cadila Healthcare Ltd and Zydus Pharmaceuticals USA Inc. The label also mentions Rx only status and special handling notes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.